DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09606 DUALITYBIO-B

Not Yet Opened 09-28 16:08:28

194.600

-2.200

-1.12%

High202.200	Low193.100	Vol514.60K
Open199.400	D1 Closing196.800	Amplitude4.62%
Mkt Cap17.68B	Tradable Cap17.68B	Total Shares90.83M
T/O100.95M	T/O Rate0.57%	Tradable Shares90.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":194.6,"timestamp":1790582908010,"preClose":196.8,"halted":0,"volume":514596,"delay":0,"changeRate":-0.011178861788617973,"floatShares":90833600,"shares":90833600,"eps":-46.5330932711996,"marketStatus":"Not Yet Opened","change":-2.2,"latestTime":"09-28 16:08:28","open":199.4,"high":202.2,"low":193.1,"amount":100949023,"amplitude":0.04624,"askPrice":194.9,"askSize":600,"bidPrice":194.6,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-18.840219423921486,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790645400000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":196.8,"openAndCloseTimeList":[[1790559000000,1790568000000],[1790571600000,1790582400000]],"volumeRatio":0.6262111181521692,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"1187913188","title":"DualityBio Adds 0.40 Million Shares After Series of Option Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=1187913188","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187913188?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:05","pubTimestamp":1790600700,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio) disclosed that 399,683 new ordinary shares were issued between 1 and 28 September 2026 through 21 separate option exercises under its Pre-IPO Equity...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160035485","title":"Movement Alert｜DUALITYBIO-B Falls 5.02% in Regular Trading, Trading at HK$204.2","url":"https://stock-news.laohu8.com/highlight/detail?id=1160035485","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160035485?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:10","pubTimestamp":1790215840,"startTime":"0","endTime":"0","summary":"On September 24, DUALITYBIO-B fell 5.02% in regular trading, trading at HK$204.2 per share, with turnover of HK$30.27 million.Within the Biotechnology sector where DUALITYBIO-B belongs, the overall...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173156900","title":"Movement Alert｜DUALITYBIO-B Rises 5.32% in Regular Trading, DB-1311 Combo First-Line SCLC ORR of 92.3% Continues to Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1173156900","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173156900?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:44","pubTimestamp":1789955054,"startTime":"0","endTime":"0","summary":"On September 21, DUALITYBIO-B rose 5.32% in regular trading, trading at HK$210.4/share, with turnover of HK$29.10 million. The stock has gained meaningfully over recent sessions, extending a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DUALITYBIO-B Rises on DB-1311 First-Line SCLC 92.3% ORR","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103165467","title":"Movement Alert｜DUALITYBIO-B Rises 5.24% in Regular Trading, DB-1311 Combo First-Line SCLC ORR of 92.3% Continues to Catalyze","url":"https://stock-news.laohu8.com/highlight/detail?id=1103165467","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103165467?lang=en_us&edition=fundamental","pubTime":"2026-09-18 11:32","pubTimestamp":1789702345,"startTime":"0","endTime":"0","summary":"On September 18, DUALITYBIO-B rose 5.24% in regular trading, trading at HK$194.0/share, with turnover of HK$106 million. The stock has continued its upward momentum following landmark clinical data...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DUALITYBIO-B Rises as DB-1311 Combo Hits 92.3% First-Line SCLC ORR","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129425995","title":"Movement Alert｜DUALITYBIO-B Rises 10.55% in Regular Trading, DB-1311 Combo Achieves 92.3% First-Line SCLC ORR at WCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1129425995","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129425995?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:51","pubTimestamp":1789368671,"startTime":"0","endTime":"0","summary":"On September 14, DUALITYBIO-B rose 10.55% in regular trading, reaching HKD 186.5 per share with turnover of HKD 187 million. The rally was driven by updated clinical data presented at the World Lung...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS Initiates Buy on DUALITYBIO-B as DB-1311 Data Impresses","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157152624","title":"Hong Kong Market Flash: DUALITYBIO-B (09606) Surges Over 9% on Encouraging WCLC Abstract for DB-1311 Combo, First-Line SCLC ORR Hits 92.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157152624","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157152624?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:28","pubTimestamp":1789367315,"startTime":"0","endTime":"0","summary":"Shares of DUALITYBIO-B (09606) rallied sharply during Friday's session, climbing more than 9% at one point. As of the latest update, the stock was trading up 8.48% at HK$183, with turnover reaching...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","BK4585","BK1161","09606","KCAI","HK0000500386.USD","LU2543165471.USD","VXUS","HK0000252152.HKD","HK0000252160.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151858347","title":"Movement Alert｜DUALITYBIO-B Drops 5.38% in Regular Trading, Weak Interim Results and Biotech Sector Selloff Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1151858347","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151858347?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:21","pubTimestamp":1789006870,"startTime":"0","endTime":"0","summary":"On September 10, DUALITYBIO-B fell 5.38% in regular trading, trading at HK$173.4 per share, with turnover of approximately HK$80.69 million.The decline was driven by a combination of disappointing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"DUALITYBIO-B Slides on Weak H1 Revenue and Sector Selloff","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117650890","title":"DUALITYBIO-B: DualityBio Ltd. Acquires Shares, Long Position Rises to 7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117650890","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117650890?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:52","pubTimestamp":1788861177,"startTime":"0","endTime":"0","summary":"DualityBio Ltd. bought 10,000 shares of DUALITYBIO-B stock at an average of HKD 174.054 per share on September 2, 2026, involving about HKD 1.74 million.Prior to the acquisition, DualityBio Ltd.'s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131492576","title":"Duality Biotherapeutics, Inc. - B: DualityBio Ltd. Acquires Shares, Long Position Rises to 7.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131492576","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131492576?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:17","pubTimestamp":1788859037,"startTime":"0","endTime":"0","summary":"On September 3, 2026, DualityBio Ltd. bought 10,000 shares of Duality Biotherapeutics, Inc. - B (09606) at an average of HKD 184.149 per share, involving about HKD 1.84 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108142102","title":"Hong Kong Stock Movement | DUALITYBIO-B (09606) Climbs Over 4% in Late Trading, New BD Breakthrough with Roche, Potential Milestone Payments Exceed $1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1108142102","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108142102?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:04","pubTimestamp":1788854659,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its stock price surge more than 4% during the late trading session, with the company announcing a new business development collaboration with Genentech, a member of the Roche...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","KCAI","09606","HK0000500386.USD","HK0000252152.HKD","VXUS","BK4585","HK0000252160.HKD","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115148072","title":"Chairman and CEO Acquires Additional Shares in DualityBio Over Two Consecutive Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=1115148072","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115148072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:40","pubTimestamp":1788781220,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange reveals that from September 2 to 3, Chairman and Chief Executive Officer Zhu Zhongyuan increased his stake in 映恩生物-B (09606) on two successive trading days.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000500386.USD","09606","BK1161","HK0000252160.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126155128","title":"DUALITYBIO-B: Zhu Zhongyuan Acquires Shares, Long Position Rises to 17.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126155128","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126155128?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:13","pubTimestamp":1788772384,"startTime":"0","endTime":"0","summary":"On September 3, 2026, Zhu Zhongyuan bought 10,000 shares of DUALITYBIO-B (09606) stock at an average of HKD 184.149 per share, involving about HKD 1.84 million.Prior to the acquisition, Zhu...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144600263","title":"DUALITYBIO-B (09606) Surges 6% in Afternoon Trade as BD Deals Exceed $7 Billion and Company Eyes US Development Role","url":"https://stock-news.laohu8.com/highlight/detail?id=1144600263","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144600263?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:04","pubTimestamp":1788419059,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its share price climb more than 6% during Tuesday's afternoon trading session, buoyed by investor optimism surrounding its expanding partnership portfolio. The stock was last...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","VXUS","LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","BK1161","BK4588","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129949172","title":"Movement Alert｜DUALITYBIO-B Rises 5.45% in Regular Trading, Multiple Brokers Maintain Buy Ratings Triggering Oversold Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1129949172","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129949172?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:30","pubTimestamp":1788417026,"startTime":"0","endTime":"0","summary":"On September 3, DUALITYBIO-B rose 5.45% in regular trading, trading at HK$185.9 per share, with turnover of HK$123 million. The rally was primarily driven by a cluster of bullish institutional...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DualityBio-B Rebounds as CMB International Keeps Buy Rating","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083997","title":"DualityBio Signs Genentech ADC Collaboration, Secures USD 45 Million Upfront, over USD 1 Billion Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083997","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083997?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:26","pubTimestamp":1788247561,"startTime":"0","endTime":"0","summary":"DualityBio signs Genentech ADC collaboration, secures USD 45 million upfront, over USD 1 billion milestonesPortfolio company DualityBio signed a global collaboration, licensing deal with Roche unit Ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4MpYtQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK1161","HK0000500386.USD","09606","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157515463","title":"Movement Alert｜DUALITYBIO-B Falls 7.29% in Regular Trading, H1 Revenue Plunges as Adjusted Net Profit Swings to Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1157515463","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157515463?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:06","pubTimestamp":1788159976,"startTime":"0","endTime":"0","summary":"On August 31, DUALITYBIO-B fell 7.29% in regular trading, trading at 185.5 HKD/share, with turnover of HKD 282 million. The selloff came as the market digested the company's disappointing interim...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"DUALITYBIO-B Plunges as Adjusted Net Profit Swings to Loss","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045587","title":"Duality Biotherapeutics (SEHK:9606) Stock Grapples With Revenue Collapse And Heavy Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045587","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045587?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:37","pubTimestamp":1788050276,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics just reminded investors what high conviction in early stage oncology really looks like. The stock closed at HK$200.2 on the day of the H1 2026 release, with the market reacting to a story that is still all about scale of losses rather than clean profitability. The headline is simple. Revenue sat at ¥219.33 million for the half, while the company booked a net loss of ¥917.55 million and a basic loss per share of ¥10.2.\nFor a company often framed as a long term growth...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-sehk9606-stock-grapples-with-revenue","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-sehk9606-stock-grapples-with-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","HK0000252152.HKD","09606","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662018061","title":"Duality Biotherapeutics Inc - Board Does not Recommend Payment of Interim Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2662018061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662018061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:35","pubTimestamp":1787913328,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606","LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061058","title":"Duality Biotherapeutics, Inc Hy Adjusted Loss Rmb626.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913284,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLXR1NRTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU2543165471.USD","HK0000500386.USD","09606","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061057","title":"Duality Biotherapeutics FY26 H1 Loss Narrows to RMB 917.55 Million; Revenue Drops 82.16% to RMB 219.33 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061057","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061057?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913245,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics FY26 H1 loss narrows to RMB 917.55 million; revenue drops 82.16% to RMB 219.33 millionDuality Biotherapeutics posted revenue of RMB 219.33 million for the six months ended June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2TQR06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","HK0000252160.HKD","09606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0795},{"period":"1month","weight":-0.028},{"period":"3month","weight":0.074},{"period":"6month","weight":-0.3941},{"period":"1year","weight":-0.4205},{"period":"ytd","weight":-0.3474}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0368},{"period":"3month","weight":0.077},{"period":"6month","weight":-0.0258},{"period":"1year","weight":-0.0569},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.","exchange":"SEHK","name":"DUALITYBIO-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DUALITYBIO-B,09606,DUALITYBIO-B股票,DUALITYBIO-B股票老虎,DUALITYBIO-B股票老虎国际,DUALITYBIO-B行情,DUALITYBIO-B股票行情,DUALITYBIO-B股价,DUALITYBIO-B股市,DUALITYBIO-B股票价格,DUALITYBIO-B股票交易,DUALITYBIO-B股票购买,DUALITYBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}